BRITE held its Year 1 Symposium on June 17th 2026 bringing together partners from across academia, industry, civic, combined authorities, NHS and SMEs and accelerators plus researchers from across the network to review progress and discuss our successes for this the first year of BRITE.

The objective of activities should be to increase sector porosity between academia and industry, reducing silos and raising awareness of priorities across the Biologics sector.

BRITE team shares experiences and challenges of place-based innovations at KEUK 2026

The BRITE Biologics Programme are pleased to announce the formation of its Scientific Advisory Board, bringing together leading experts from across the biologics, biotechnology, regulatory, academic, and clinical research sectors. The board will provide independent oversight, strategic guidance, and scientific expertise as BRITE advances its mission to accelerate innovation in biologics development, biomanufacturing, and health technologies across the Liverpool City Region.

BRITE team shares expertise and builds partnerships to combat antimicrobial resistance.​

We currently have a funding opportunity for researchers working in the Biologics space. The aim of the fund is to advance potential innovations beyond proof

  “This was an exciting opportunity to bring together a broad range of BRITE stakeholders with multidisciplinary experience and we were delighted to hear input

BRITE, a cross-sector partnership which includes universities and industry, has been awarded close to £5m by Research England’s Connecting Capability Fund (CCF) to develop essential capacity